Robert I Tepper's Net Worth

$1.83 Million

Who is Robert I Tepper?

Robert I Tepper has an estimated net worth of $1.83 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., CONSTELLATION PHARMACEUTICALS INC, Fulcrum Therapeutics, Inc., Revolution Medicines, Inc., PLIANT THERAPEUTICS, INC., Editas Medicine, Inc., Jounce Therapeutics, Inc., Voyager Therapeutics, Inc., Blueprint Medicines Corp, Nurix Therapeutics, Inc., bluebird bio, Inc., Global Blood Therapeutics, Inc., Sage Therapeutics, Inc., Relay Therapeutics, Inc., MyoKardia Inc, Neon Therapeutics, Inc., Foundation Medicine, Inc., ZAFGEN, INC., Cerulean Pharma Inc., Allena Pharmaceuticals, Inc., Decibel Therapeutics, Inc., Eleven Biotherapeutics, Inc., CytomX Therapeutics, Inc., Kala Pharmaceuticals, Inc., and MILLENNIUM PHARMACEUTICALS INC.

SEC CIK

Robert I Tepper's CIK is 0001192595

Past Insider Trading and Trends

2004 was Robert I Tepper's most active year for acquiring shares with 8 total transactions. Robert I Tepper's most active month to acquire stocks was the month of May. 2004 was Robert I Tepper's most active year for disposing of shares, totalling 12 transactions. Robert I Tepper's most active month to dispose stocks was the month of September. 2017 saw Robert I Tepper paying a total of $3,010,000.00 for 2,803,924 shares, this is the most they've acquired in one year. In 2017 Robert I Tepper cashed out on 10,843,080 shares for a total of $2,240,647.70, their largest year based on trade value.